Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 3Active not recruiting 3Recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Carcinoma, Non-Small-Cell Lung 9Uterine Cervical Neoplasms 8Squamous Cell Carcinoma of Head and Neck 5Urinary Bladder Neoplasms 3Small Cell Lung Carcinoma 3Neuroblastoma 3Medulloblastoma 3Ganglioneuroblastoma 3Gallbladder Neoplasms 3Cholangiocarcinoma 3Urethral Neoplasms 2Ureteral Neoplasms 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Brenner Tumor 2Vulvar Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sarcoma 1Rhabdoid Tumor 1Recurrent Uterine Corpus Carcinoma 1Recurrence 1Prostatic Neoplasms 1Pinealoma 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neuroendocrine Tumors 1

Interventions

Gemcitabine 79Cisplatin 56pembrolizumab 32Paclitaxel 28Carboplatin 24Docetaxel 19Radiotherapy 17Mitomycin 16Doxorubicin 15atezolizumab 14BCG Vaccine 14Nivolumab 13Cystectomy 13Filgrastim 11vinflunine 10Methotrexate 10Vinblastine 9Fluorouracil 95-aminolevulinic acid hexyl ester 9Sunitinib 7Early Intervention, Educational 7durvalumab 6avelumab 6Taxes 6Methods 6Cystoscopy 6Albumin-Bound Paclitaxel 6enfortumab vedotin 5Trastuzumab 5Surveys and Questionnaires 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Urinary Bladder Neoplasms × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT04383743 2025-09-18

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

University of Washington

Phase 2 Completed
17 enrolled 12 charts
Genitourinary

Urinary Bladder Neoplasms

NCT03617913 2023-01-06

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

Mayo Clinic

Phase 2 Completed
2 enrolled 8 charts
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT01938573 2017-10-20

Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer

University of Washington

Phase 1/2 Completed
21 enrolled 4 charts
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡